The program Congress established to speed commercial development of vaccines and treatments to counter a potential bioterror attack is moving too slowly ...
Melissa Quinn previously worked for The Daily Signal as a senior news reporter. Seeking a more robust defense in the event of a bioterrorist attack on the United States, the Bush administration ...
In an effort to salvage the deeply troubled $5.6 billion Project BioShield program, Congress is scrambling to pass new legislation that would inject a fresh $1 billion into the project while ...
Acambis'smallpox vaccine will be among the first biodefense products to come to market under the three-month old US BioShield law. Three years after the terrorists attacks and anthrax scare in the ...
GERMANTOWN, Md., June 10, 2020 (GLOBE NEWSWIRE) -- Orgenesis Inc. (ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and ...
When Congress created Project BioShield four years ago, lawmakers believed that offering developers contracts guaranteeing the acquisition of new vaccines and drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results